SAM Pharmaceutical Opens New Manufacturing Facility in Ogun

On April 8, 2026, SAM Pharmaceutical Ltd inaugurated a new manufacturing facility in Ota, Ogun State, marking a significant milestone in the company's evolution and Nigeria's pharmaceutical sector. The event was attended by key stakeholders, including Ogun State Deputy Governor Noimot Salako-Oyedun, Dr.

Iziq Salako from the Ministry of Health, and NAFDAC Director General Prof. Mojisola Adeyeye.

The new plant is designed to comply with World Health Organization's current Good Manufacturing Practices (cGMP) standards and is expected to produce 400 million tablets, 50 million capsules, two million bottles of liquid formulations, and one million sachets monthly. This expansion aligns with Nigeria's goal to increase local pharmaceutical manufacturing and reduce dependence on imports.

SAM Pharmaceutical's Chairman and Managing Director, Amit Bhojwani, emphasized the facility's role in the company's future growth and commitment to quality assurance and regulatory compliance. The inauguration also highlighted the company's involvement in public health initiatives, including a deworming program targeting 5,000 children in Ogun State.